Introduction
Development of an organism requires temporal and spatial control of gene transcription. The Polycomb group (PcG) proteins, first described in Drosophila, epigenetically maintain gene silencing through cell division, and thereby help define the developmental fates of cell lineages. Although the cohesin complex was first recognized for its role in chromosome segregation and cell division, it has become apparent that it also plays multiple direct and essential roles in transcription of active genes important for growth and development. It has been assumed that cohesin and PcG complexes by and large play independent and generally antagonistic roles to each other in the transcription of key developmental genes. Recent evidence from Drosophila, however, unexpectedly reveals that cohesin and the PRC1 PcG complex directly and functionally interact to modulate both gene silencing and transcription of active genes. These findings raise intriguing questions regarding the potential roles of such interactions in human development and cancer. Here, we provide a brief review of the roles of cohesin and PcG proteins in gene expression, and then discuss the evidence for cohesin-Polycomb interactions and the current ideas about the functions of these interactions.
Functions of Polycomb Complexes in Gene Silencing and Development
The Polycomb proteins were discovered in genetic screens in Drosophila based on their dominant loss-of-function homeotic phenotypes, and have since been found to be critical regulators of stem cell identity, embryonic development, and oncogenesis in mammals [1] [2] [3] . Molecular and biochemical studies have shown that many of the Polycomb proteins are present in complexes that modify chromatin [1] [2] [3] . The two most studied complexes are Polycomb Repressive Complex 1 (PRC1) and PRC2 ( Figure 1A ). PRC2 contains a methyltransferase, Enhancer of zeste [E(z)], that methylates the lysine 27 residue of histone H3 to form H3K27me3, a modification that spreads in large domains of many kilobase pairs (kbp) over silenced genes. The Polycomb (Pc) subunit of the PRC1 complex contains a chromodomain that binds to H3K27me3, thereby assisting the spread of PRC1 over large regions. PRC1 contains the Sex combs extra (Sce, dRing) subunit, which mono-ubiquitinates the carboxy-terminal tail of histone H2A to form H2Aub, a modification that can also spread over large regions ( Figure 1A ) [4] . H2Aub is present only at low levels over some silenced genes, which may reflect de-ubiquitination by another Polycomb complex, PR-DUB [5] . Current evidence argues that the histone modifications made by PcG complexes are critical for silencing at many, but not all, genes [2, 3, 5] .
In Drosophila, Polycomb protein complexes are recruited via DNA binding proteins to Polycomb Response Elements (PREs) while Polycomb recruitment in mammals occurs via multiple mechanisms, including both PRE-like mechanisms and via interactions with long non-coding RNAs [3, 6, 7] . In contrast to Drosophila, vertebrates also have several different PRC1 and PRC2 complexes, reflecting the presence of multiple orthologs of key subunits. For instance, CBX2, CBX4, CBX6, CBX7, and CBX8 are all Pc orthologs, and appear to have cell-type-specific functions [2] .
The Cohesin Complex Mediates Sister Chromatid Cohesion and Influences Development in a Dosage-Sensitive Manner The cohesin protein complex and associated regulatory factors ( Figure 1B ) were originally discovered in yeast genetic screens and vertebrates because they are essential for mitotic and meiotic sister chromatid cohesion, but they also participate in DNA repair and gene transcription [8] [9] [10] . The Smc1, Smc3, Rad21 and Stromalin (SA) cohesin subunits form a ring-like structure that encircles DNA. Cohesin is topologically loaded along chromosomes during interphase by the kollerin complex consisting of the Nipped-B adherin and the Mau-2 protein, and is removed by the releasin complex consisting of Pds5 and Wapl. Sister chromatid cohesion ensures accurate chromosome segregation upon cell division. Thus, severe disruption of cohesin function results in aneuploidy and frequent cell death. However, studies in Drosophila, zebrafish, mouse, and human reveal that reduced cohesin or kollerin dosage alters gene expression and development without evident defects in sister chromatid cohesion and chromosome segregation [8] . In humans, reduced dosage of the NIPBL (Nipped-BLike) kollerin subunit and missense mutations in cohesin subunits cause Cornelia de Lange syndrome (CdLS), which displays diverse structural and mental birth defects [11] . Mutations affecting the HDAC8 deacetylase that recycles the SMC3 cohesin subunit and reductions in Rad21 function cause phenotypes closely overlapping those seen in CdLS [12, 13] . Collectively these syndromes are known as cohesinopathies.
Cohesin Directly Influences Transcription of Genes That Control Growth and Development
A role for cohesin in gene expression was revealed in a genetic screen designed to detect genes that facilitate communication between distant transcriptional enhancers and promoters. Since that time, cohesin's role in enhancerpromoter communication has been confirmed in fly and mammalian cells [14] [15] [16] [17] [18] [19] . In particular, chromosome conformation capture (3C) experiments argue that one role of cohesin is to facilitate enhancer-promoter communication by stabilizing long DNA loops. In fact, genome-wide mapping of long-range interactions using techniques derived from 3C confirm that cohesin is critical for many long-range gene regulatory interactions [20] [21] [22] [23] .
Genome-wide studies in Drosophila and mammalian cells reveal that cohesin binds to a large subset of transcriptionally active genes, many of which encode transcription and signaling factors important for growth and development [8] . Cohesin binding is high near active transcription start sites and transcriptional enhancers, but is generally undetectable at Polycomb silenced genes marked by H3K27me3 [16, 18, 24, 25] . Gene promoters that bind cohesin show a high level of transcriptional pausing, where RNA polymerase II (Pol II) transcribes some 30 to 40 nucleotides and then stops before it is released into elongation ( Figure 2 ) [18, 26] . Transition from pausing to elongation requires phosphorylation of the NELF (negative elongation factor) and DSIF (DRB sensitivity inducing factor) pausing complexes, and the serine 2 residues of the heptapeptide repeats in the carboxy-terminal domain (CTD) of the Rpb1 Pol II subunit ( Figure 2 ) [27] . Depending on the gene and cell type, cohesin can either facilitate or hinder the transition of paused Pol II to elongation [18, 26] . In many cases this likely reflects cohesin's role in enhancer-promoter communication, but cohesin also appears to have additional roles at the promoters of many genes [18] .
Cohesin-Polycomb Interactions
Genetic studies suggest an antagonistic connection between Polycomb proteins and cohesin [28] [29] [30] [31] . In particular, mutations in releasin genes increase cohesin binding and counteract Polycomb silencing, whereas decreasing cohesin dosage or chromosome binding enhances Polycomb silencing. The in vivo antagonism between cohesin and PRC1 fits nicely with the discovery that silenced genes marked by the PRC2-generated H3K27me3 modification do not bind cohesin, outside of narrow peaks at some PREs [25] . Combined with the genetic studies, this led to the early view that cohesin may help prevent spreading of Polycomb complexes into active genes, and vice versa.
This view, however, was challenged by the unexpected discovery that cohesin subunits co-purify with the PRC1 complex from Drosophila nuclear extracts [32] . This model also didn't explain how a small number of genes broke the general rule, with cohesin spreading across large domains of several kbp together with H3K27me3 and H2Aub [4, 33] . These rare genes all encode key developmental regulators, such as the invected and engrailed homeobox genes, the Enhancer of split gene complex, and the Psc and Su(z)2 Polycomb genes. This unusual cohesin-H3K27me3-H2Aub state proved to be cell-type dependent, and when it occurs, the genes are not fully silenced, and depletion of either cohesin or PRC1 causes large increases in transcription. Like 'poised' bivalent genes in mammalian cells [34] these genes also have the H3K4me3 histone modification, a mark of active genes, at the transcription start site.
The recent discovery that PRC1 is present at active cohesin-binding genes resolves the paradoxical findings that cohesin and PRC1 interact biochemically, while PcG-silenced genes lack cohesin [31] . This discovery arose from studies on the PcG-regulated genes invected and engrailed in the developing wing imaginal disc. The invected and engrailed genes encode homeoproteins that determine posterior identity and are expressed in the posterior compartment of the larval wing imaginal disc but are Polycomb-silenced in the anterior compartment. Genomic ChIP on chromatin prepared separately from posterior and anterior compartments showed that, as expected, cohesin is present at high levels on these genes only in the posterior cells where they are transcribed, and H3K27me3 is high only in anterior cells, where they are silenced. Unexpectedly, however, multiple PRC1 subunits, including Pc, Ph and Psc, are present at virtually equal levels in both posterior and anterior disc cells [31, 35] . The presence of multiple subunits indicates that the core PRC1 complex is present at both the active and silenced invected and engrailed genes [31] . PcG protein binding at PREs of the active Ubx (Ultrabithorax) gene in the haltere imaginal disc has also been reported [36] .
Unexpectedly, genome-wide mapping of three PRC1 subunits in wing discs reveals PRC1 binding within the transcription units and close to the promoters of several highly-transcribed constitutively expressed genes, such as myc, and multiple ribosomal protein genes that lack H3K27me3. Importantly, PRC1 binding to active genes is restricted to those that bind cohesin. Genomic ChIP in cultured cells, a more homogenous cell population, confirms that there is extensive cohesin-PRC1 overlap on active genes, although H2Aub levels are low to undetectable [4, 31] .
ChIP cannot determine if cohesin and PRC1 co-occupy active genes, or if there is switching back and forth between cohesin-only and PRC1-only conditions. Additional evidence, however, strongly supports co-occupancy. Depletion of cohesin in cultured cells decreases the levels of PRC1 at active genes, and simultaneously increases PRC1 levels at silenced genes marked by H3K27me3 [31] . Combined with the prior finding that cohesin and PRC1 interact biochemically [32] , this argues that cohesin recruits PRC1 and/or stabilizes PRC1 binding at active genes. The increase in PRC1 at silenced genes marked by H3K27me3 upon cohesin depletion further argues that cohesin sequesters enough PRC1 at active genes to limit the amount of PRC1 available for binding to silenced genes (Figure 2 ). Reducing cohesin releases PRC1 to relocate to silenced genes marked by H3K27me3.
This model can explain the in vivo antagonism between cohesin and PRC1. When a heterozygous Pc mutation limits the amount of PRC1 available for silencing, resulting in homeotic transformations, reducing cohesin dosage releases sufficient PRC1 from active genes to restore silencing. In this view, the increased cohesin binding that occurs in pds5 and wapl releasin mutations sequesters too much PRC1 at active genes, mimicking the effect of PRC1 mutations. In the presence of normal PRC1 levels, cohesin and Nipped-B mutations result in excess available PRC1, and over-silencing that causes homeotic transformations opposite to those caused by Pc mutations [28, 31] . This model differs significantly from the earlier view, in which cohesin and PRC1 battle for binding to a gene, with the winner determining whether the gene is active or silenced. A key point of the sequestration model is that the cohesin at active genes balances the levels of PRC1 to ensure appropriate levels of gene silencing. This raises the intriguing possibility that substantial changes in active gene transcription can cause global changes in gene silencing.
The PRC1 Complex Modifies RNA Polymerase Function at Active Genes Do PcG proteins have a regulatory function at active cohesin-binding genes? The evidence suggests that PRC1 promotes polymerase pausing. Upon depletion of the Ph subunit of PRC1 in cultured cells, the total level of Pol II within active gene bodies increases, but the level of serine 2 phosphorylated Pol II decreases, correlating with lower mRNA levels [31] . Although H2Aub is usually undetectable at active genes, depletion of the PRC1 subunit Sce that ubiquitinates H2A has the same effect as Ph depletion on Pol II, raising the possibility that transient H2A modification may contribute to transcriptional pausing (Z. Misulovin, A. Koenig, C.A. Schaaf, D.D., unpublished).
Phosphorylation of the Pol II CTD by P-TEFb facilitates binding of elongation and RNA processing proteins needed to produce mRNA from the nascent transcripts. Therefore, a likely role for PRC1 at active genes is to prevent Pol II from entering into elongation until the pausing factors and Pol II have been fully phosphorylated. In the absence of PRC1, entry of incompletely phosphorylated Pol II decreases binding of RNA processing factors needed for efficient mRNA production, and could also reduce binding of elongation factors and the rate of nascent RNA synthesis.
The effect of depleting PRC1 on transcription differs from that of cohesin depletion. Cohesin depletion reduces both cohesin and PRC1 binding, and there is usually a decrease in both total and phosphorylated Pol II in the bodies of active genes [18] . Depletion of PRC1, however, rarely decreases cohesin levels, and thus cohesin remains at the active genes and appears to be required for the increase in Pol II in gene bodies. It is unclear how cohesin facilitates the entry of Pol II into the gene body before it is fully phosphorylated. This finding suggests, however, that in addition to its role in facilitating enhancer-promoter Figure 2 . The PRC1 sequestration model. Genomic chromatin immunoprecipitation shows that in Drosophila, PRC1 is distributed between Polycomb silenced genes (left), marked with H3K27me3 made by the PRC2 complex, and active genes (right) that bind cohesin. The bulk of PRC1 is present at active genes, and upon reduction in cohesin levels, PRC1 released from active genes relocates to silenced genes, indicating that sequestration of PRC1 by cohesin at active genes limits the amount of PRC1 available for silencing. This model is consistent with the in vivo genetic antagonism between PRC1 and cohesin. RNA polymerase (Pol II) at cohesin-binding promoters is transcriptionally paused by the NELF and DSIF pausing factors. Phosphorylation (pink circles) of NELF, DSIF and Pol II by the P-TEFb kinase releases Pol II into elongation. Current data argue that PRC1 prevents premature release of paused Pol II into elongation before it is fully phosphorylated (see text). In rare cases, some genes marked by H3K27me3 also bind cohesin (restrained). These genes also bind PRC1, but are not silenced. Both PRC1 and cohesin are needed to keep transcription at a low level. It is currently unknown if this special state represents a transition between the silenced and active states, or is a special state that maintains transcription at a critical level. These cases are very similar to bivalent genes seen in mammalian embryonic stem cells. This figure is adapted from [31] .
looping, cohesin has additional roles in controlling Pol II function at the promoter.
The proposed function of PRC1 at active gene promoters is likely to be closely related to its role in silencing. General transcription factors are present at some PcG-silenced promoters, but there is little or no transcription, suggesting that Pol II is restrained by PRC1 [37] . Although most silenced genes marked by H3K27me3 lack paused Pol II, lack of the Esc (extra sex combs) protein essential for PRC2 activity in embryos leads to the appearance of promoter-proximal paused Pol II at many inactive genes, suggesting that PRC1 is still present and blocks entry of Pol II into elongation [38] . Similarly, PRC1 restrains paused Pol II at bivalent gene promoters in mouse embryonic stem cells [34, 39] .
Does PRC1 Participate in Enhancer-Promoter Looping?
The functional interactions between cohesin and PRC1 raise the question of whether or not PRC1 supports cohesin's role in long-range enhancer-promoter looping. Indeed, it has recently been reported that PRC1 facilitates an enhancer-promoter interaction to activate the Meis2 gene in developing mouse midbrain [40] . Long-range looping and interchromosomal interactions between PREs have been intensively studied in Drosophila since the discovery of chromosome pairing-dependent silencing by a PRE from the engrailed gene, and the data clearly demonstrate extensive long-range looping between active PREs [41] [42] [43] . However, analysis of genome-wide PRC1 mapping data [31] reveals that while cohesin binds to essentially all active distant enhancers, and PRC1 is present at virtually all cohesin-binding promoters, PRC1 is detected at only a third of the distant enhancers (D.D., unpublished). This is similar to the frequency with which Pol II is detected at the distant enhancers, and cohesin depletion similarly reduces both Pol II and PRC1 levels at enhancers. The simplest interpretation, therefore, is that the PRC1 and Pol II detected at the enhancers are actually bound to the promoter, but enhancer-promoter looping allows some crosslinking to the enhancer. This argues against the general idea that PRC1 contributes to enhancer-promoter looping. In contrast, 3C analysis supports the idea that cohesin, which can be detected at many PREs at silenced genes, supports looping between the PREs upstream of the invected and engrailed genes [31] .
Are Cohesin-PRC1 Interactions Important For Human Development and Cancer? The cohesin-PRC1 interactions detected in Drosophila may have implications for human cohesinopathies and cancers. Cells from individuals with genetically distinct forms of CdLS show similar patterns of changes in gene expression [24] , supporting the view that cohesin's role in controlling transcription is central to CdLS etiology. New evidence indicates that PRC1 regulates transcription of many active genes in quiescent mouse lymphocytes [44] and is present at several active genes in human fibroblasts [45] . The generality of these intriguing findings has yet to be explored, but if cohesin controls association of mammalian PRC1 with active genes and balances gene silencing, increases in gene silencing may contribute to the development deficits that occur in cohesinopathies. There are also potential roles of cohesin-PRC1 interactions in cancer, given the striking correlation between high levels of cohesin and poor prognosis in many tumors, the frequent occurrence of cohesin and PcG protein mutations in cancer, and the evolutionarily conserved positive modulation of myc gene transcription by cohesin [2, 46, 47] .
Looking Forward
Given the high sensitivity of Drosophila gene expression and development to functional cohesin-PRC1 interactions, and the potential involvement of such interactions in human development and cancer, it is important to determine if and how similar interactions occur in mammals. Addressing this question, however, is complicated by the diversity of mammalian PRC1 complexes. It is possible, for example, that only one or a few of the many human PRC1 complexes work together with cohesin. Mammals also have two forms of cohesin in somatic cells that differ in their roles in gene regulation, adding additional complexity [48] . Better definition of the molecular interactions between Drosophila PRC1 and cohesin may be helpful in the search for cohesin-PRC1 interactions in vertebrates. Knowing which residues of which cohesin subunits interact with which residues of which PRC1 subunits could potentially eliminate some mammalian PRC1 complexes from consideration, and highlight others as likely candidates.
